Ways to Reduce the Missouri Budget

The Insane Bloat of the Missouri Department of
Mental Health Budget from 1971 to 2014 – almost $2 Billion and Rapidly Rising

Missouri DMH Budgets

The introduction and passage of legislation designed to curb psychiatric fraud and abuse can contribute to the reduction of the Department of  Mental Health budget. For examples of Model Legislation, click here.

Reports show that:

* 10% to 25% of mental health practitioners sexually abuse patients.

* Psychiatry has the worst fraud track record of all medical disciplines.

* The largest health care fraud suit in history [$375 million] involved the smallest sector of healthcare–psychiatry.

* An estimated $20-$40 billion is defrauded in the mental health industry in any given year.


1.   Establish or increase the number of psychiatric fraud investigation units to recover funds that are embezzled in the mental health system.

2.   Clinical and financial audits of all government-run and private psychiatric facilities that receive government subsidies or insurance payments should be done to ensure accountability; statistics on admissions, treatment and deaths, without breaching patient confidentiality, should be compiled for review.

3.   A list of convicted psychiatrists and mental health workers, especially those convicted and/or disciplined for fraud and sexual abuse should be kept on state, national and international law enforcement and police agencies databases, to prevent criminally convicted and/or deregistered mental health practitioners from gaining employment elsewhere in the mental health field.

4.   No convicted mental health practitioner should be employed by government agencies, especially in correctional/prison facilities or schools.

5.   The DSM and/or lCD (mental disorders section) should be removed from use in all government agencies, departments and other bodies including criminal, educational and justice systems.

6.   Establish rights for patients and their insurance companies to receive refunds for mental health treatment which did not achieve the promised result or improvement, or which resulted in proven harm to the individual, thereby ensuring that responsibility lies with the individual practitioner and psychiatric facility rather than the government or its agencies.

7.   None of the mental disorders in the DSM/ICD should be eligible for insurance coverage because they have no scientific, physical validation. Governmental, criminal, educational and judicial agencies should not rely on the DSM or lCD (mental disorders section).

8.   Provide funding and insurance coverage only for proven, workable treatments that verifiably and dramatically improve or cure mental health problems.

We think it is time to call psychiatry and psychology for what they are — failed pseudo sciences with no basis in fact, pseudo sciences that harm their recipients and line the pocketbooks of their practitioners.

Mental Health Care Facts

Mental Health Care Facts

In 2001 the U.S. spent $85 billion on mental health services.

In 2008 the U.S. spent $170 billion on mental health services.

In 2014 Missouri has budgeted over $1.8 billion on mental health services, of which over $1 billion comes from the Federal government.

In 2015 the U.S. is expected to spend $280 billion on mental health services.

The public, through Medicaid and Medicare programs, covers 60% of this cost.

These figures do not include the costs of SSI (Supplemental Security Income) and SSDI (Social Security Disability Insurance) disability programs. The lifetime cost of caring for an 18-year-old who goes onto disability for mental illness can be expected to exceed $2 million.

In 1990 11.16 million people in the U.S. were treated for psychiatric disorders compared to 21.77 million people in 2003. In 1990 1.47 million people were on U.S. government disability roles compared to 3.25 million people in 2003.

This situation is not getting better. People are not getting well from psychiatric care. Perhaps you know someone on disability or who is in psychiatric treatment. Are they getting well?

The long-term recovery rate for schizophrenia patients is 30% better if they are not taking anti-psychotic drugs.

Virtually anyone at any given time can temporarily meet the criteria for bipolar disorder or ADHD.

120 million people worldwide have been diagnosed with mental disorders and placed on psychiatric drugs as “treatment.”

There are no medical or scientific tests that can prove mental disorders are medical conditions. Psychiatric diagnosis is based solely on opinion.

The fact is, there are many medical conditions, that undetected and untreated, can appear as psychiatric ‘symptoms. There are non-harmful, non-drug solutions to treating problems of mood, attention, behavior that do not require a psychiatric diagnosis or psychiatric “treatment” (drugs) but can be effectively treated with standard medical, not psychiatric, treatment.

CCHR has compiled all international drug regulatory warnings and studies about psychiatric drug risks into an easy to search psychiatric drug database.

Support CCHR St. Louis so that we may continue to spread the word about psychiatric fraud and abuse.

Amazon will now donate 0.5% of the price of your eligible AmazonSmile purchases to Citizens Commission On Human Rights of St. Louis when you shop at AmazonSmile.

Citizens Commission on Human Rights STL

PowerShares Dynamic Pharmaceuticals

PowerShares Dynamic Pharmaceuticals (PJP)


This graph shows the price per share over the last few years for an investment fund based on the common stocks of 30 U.S. pharmaceuticals companies. (Top 10 holdings: Johnson & Johnson, Pfizer, Merck, Amgen, Eli Lilly, Bristol-Myers Squibb, Biogen, Gilead Sciences, Depomed, Questcor.) There is over $1 billion invested in this fund.

No, this is not a recommendation to run to your broker and buy these shares; although if you’d like to sell your shares we would not object. We might, however, whisper “blood money” under our breath.

In all seriousness, many people are making huge amounts of money off the pharmaceutical industry. As it was explained to me once by the CEO of a large company in the insurance industry, “We make our money on the misfortunes of others.”

Actually, this would not be such a major issue if it were not for the corrupt alliance between the psychiatric and pharmaceutical industries.

experimental stage With 30 million Americans having taken antidepressants for a “chemical imbalance” that psychiatrists admit is a pharmaceutical marketing campaign, not scientific fact, it is no wonder that the conflict of interest between psychiatry and Big Pharma perpetuates.

The American Psychiatric Association is steeped in a conflict of
interest with the pharmaceutical industry. After all, it has made at least $40 million just in sales of its Diagnostic and Statistical Manual of Mental Disorders (DSM), often called Diagnosis as a Source of Money, the billing bible that psychiatrists use for insurance reimbursement for “treatment” which is most often psychotropic drugs.

The campaign to “Stop the Stigma” of “Mental Illness” was launched by the Pharmaceutical Industry. With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by those who benefit from more and more people being labeled mentally ill — pharma, psychiatry and pharmaceutical front groups. The “Founding Sponsors” of the National Alliance on Mental Illness (NAMI) campaign to stop the “stigma” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.

Controversy swelled around the fifth edition of the DSM, known as DSM-5. One study suggested that the 900-page bible of mental health published in May 2013 is rife with financial conflicts of interest. Nearly 70 percent of DSM-5 task force members reported financial relationships with pharmaceutical companies — up from 57 percent for the previous edition.

St. Louis has not been immune to the fallout from psychiatric drugs. On January 15, 2013, 34-year-old Sean Johnson walked onto the Stevens Institute of Business & Arts campus and shot the school’s financial aid director once in the chest, then shot himself in the torso. Johnson had been taking prescribed drugs for an undisclosed mental illness.

Remember that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior or study problems as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful.

It is vital that you, your family and associates watch the video documentary “Making A Killing – The Untold Story of Psychotropic Drugging”. Containing more than 175 interviews with lawyers, mental health experts, the families of psychiatric abuse victims and the survivors themselves, this riveting documentary rips the mask off psychotropic drugging and exposes a brutal but well-entrenched money-making machine. The facts are hard to believe, but fatal to ignore. Watch the video online by clicking here.

Boston Children’s Hospital Psychiatric Unit and Justina Pelletier’s 13 month incarceration

Boston Children’s Hospital Psychiatric Unit and Justina Pelletier’s 13 month incarceration

The international mental health watchdog organization, Citizens Commission on Human Rights, is calling on Massachusetts State Attorney General to investigate Boston Children’s Hospital Psychiatric Unit in the case of Justina Pelletier’s 13 month incarceration.

For thirteen months, Lou and Linda Pelletier’s youngest daughter, Justina, has been a prisoner at the hands of Boston Children’s Hospital Psychiatric Unit accused of suffering from an obscure “mental disorder,” Somatoform, which a leading psychologist describes as being “nothing more than a destructive and unreliably applied label.” In deteriorating health, and confined to a wheelchair, the 15-year-old learned this week that there will be no pardon from the Massachusetts Psychiatric Puritans.

After months of fighting for the teenager’s freedom, on March 25, the Pelletiers were summarily dismissed by the state’s inquisitors—the Juvenile Court—and denied custody of their ailing daughter. Juvenile Court Judge, Joseph Johnson’s reason for denying the Pelletier’s right to decide their daughter’s medical treatment was his belief that the Pelletiers will not “comply” with the state’s directives.

Click here to read the full article.

Fort Hood Shooting: A Wake-up Call for Lawmakers

Fort Hood Shooting: A Wake-up Call for Lawmakers

Violence and psychiatric drugs—a deadly formula America is becoming too intimately familiar with. The mental health watchdog group, Citizens Commission on Human Rights says that rather than continually sending heartfelt condolences to the families of the victims, it is time for lawmakers to investigate the connection between prescription psychiatric drugs and violence.

America learned within hours of the April 2nd shooting at Ft. Hood that four people were dead (including the shooter) and 16 had been wounded in the attack. The shooter, 34-year old Army Specialist, Ivan Lopez, served in Iraq for four months in 2011 and according to The New York Times, Secretary of the Army, John McHugh, said Lopez had been “examined by a psychiatrist within the last month, but showed no signs that he might commit a violent act.” Secretary McHugh further explained to the Senate Armed Services Committee that Lopez “had been prescribed Ambien, a sleep aid, and other medication to treat anxiety and depression.”

CCHR says this sounds sadly familiar to the September 2013 Washington Navy Yard attack by Aaron Alexis, who had been taking the antidepressant, Trazadone, when he killed twelve innocent people.

CCHR continues that, “psychiatric treatment, in the form of prescription mind-altering drugs, once again is connected to a mass shooting. Yet, despite data showing a connection between psychiatric mind-altering drugs and violence, lawmakers have yet to investigate the connection.”

Click here to read the full article.

Ambien (generic name zolpidem) is a non-benzodiazepine hypnotic and anti-anxiety drug often prescribed for insomnia, and whose known side effects include aggressive behavior, agitation, anxiety, confusion, fear, hallucinations, hostility, psychosis, rage, suicide attempts, and transient amnesia.